Tompkins Financial Corp Myriad Genetics Inc Transaction History
Tompkins Financial Corp
- $953 Million
- Q2 2024
A detailed history of Tompkins Financial Corp transactions in Myriad Genetics Inc stock. As of the latest transaction made, Tompkins Financial Corp holds 840 shares of MYGN stock, worth $18,706. This represents 0.0% of its overall portfolio holdings.
Number of Shares
840
Previous 840
-0.0%
Holding current value
$18,706
Previous $17,000
17.65%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding MYGN
# of Institutions
237Shares Held
92.7MCall Options Held
117KPut Options Held
113K-
Black Rock Inc. New York, NY15.2MShares$337 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$224 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA8.26MShares$184 Million0.04% of portfolio
-
Camber Capital Management LP Boston, MA5.5MShares$122 Million3.72% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.4MShares$98 Million0.05% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $1.8B
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...